Impact of comorbidity on therapeutic decision-making in head and neck cancer: Audit from a comprehensive cancer center in India

Head and Neck

Volumn 34, Issue 9, 2012, Pages 1251-1254

  Baijal, Gunjan ^a   Gupta, Tejpal ^b   Hotwani, Chandni ^a   Laskar, Sarbani Ghosh ^a   Budrukkar, Ashwini ^a   Murthy, Vedang ^b   Agarwal, Jai Prakash ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b Advanced Centre for Treatment   (India)

Author keywords

comorbidity; decision making; head and neck cancer; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEAD AND NECK CANCER; HEPATITIS; HUMAN; HYPERTENSION; INDIA; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MYELOPROLIFERATIVE DISORDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; INDIA; MALE; MEDICAL AUDIT; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84865030766     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21897     Document Type: Article

References (19)

1. Feinstein AR,. Pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970; 23: 455-468.
2. Valderas JM, Starfield B, Sibbald B, Salibury C, Ronald M,. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7: 357-363.
3. deGroot V, Beckerman H, Lankhorst GJ, Bouter LM,. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003; 56: 221-229. (Pubitemid 36513483)
4. Yancik R, Ganz PA, Varricchio CG, Conley B,. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 2001; 19: 1147-1151. (Pubitemid 32176292)
5. Altekruse SF, Kosary CL, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975-2007, National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER website, 2010.
6. Paleri V, Wight RG, Silver CE, et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol 2010; 46: 712-719.
7. Piccirillo JF,. Importance of comorbidities in head and neck cancer. Laryngoscope 2000; 110: 593-602. (Pubitemid 30198711)
8. Charlson ME, Pompei P, Ales KL, Mackenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
9. Kaplan MH, Feinstein AR,. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387-404.
10. Singh B, Bhaya M, Stern J, et al. Validation of the Charlson comorbidity index in patients with head and neck cancer: a multi-institutional study. Laryngoscope 1997; 107 (11 Pt 1): 1469-1475. (Pubitemid 27481468)
11. Borggreven PA, Kuik DJ, Langendijk JA, Doornaert P, De Bree R, Leemans CR,. Severe comorbidity negatively influences prognosis in patients with oral and oropharyngeal cancer after surgical treatment with microvascular reconstruction. Oral Oncol 2005; 41: 358-364. (Pubitemid 40387864)
12. Singh B, Bhaya M, Zimbler M, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998; 20: 1-7.
13. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL,. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002; 112: 1988-1996. (Pubitemid 35283461)
14. Reid BC, Alberg AJ, Klassen AC, et al. A comparison of three comorbidity indexes in a head and neck cancer population. Oral Oncol 2002; 38: 187-194. (Pubitemid 34164570)
15. Piccirillo JF, Lacy PD, Basu A, Spitznagel EL,. Development of a new head and neck cancer-specific comorbidity index. Arch Otol Head Neck Surg 2002; 128: 1172-1179. (Pubitemid 35168108)
16. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP,. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 2007; 117: 835-840. (Pubitemid 46699354)
17. Terrell JE, Ronis DL, Fowler KE, et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 401-408. (Pubitemid 38456313)
18. El-Deiry MW, Futran ND, McDowell JA, Weymuller EA Jr, Yueh B,. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2009; 135: 380-384.
19. Piccirillo JF, Spitznagel EL Jr, Vermani N, Costas I, Schnitzler M,. Comparison of comorbidity indices for patients with head and neck cancer. Med Care 2004; 42: 482-486.